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encing the natural history of hepatitis C virus (HCV) infection and
treatment response. Accelerated lymphocyte telomere shorten-
ing in HCV infection correlates with adverse clinical outcomes.
Critical telomere shortening generates double-stranded DNA
breaks (DSB) inducing the DNA damage response, leading to rep-
licative senescence. The phenotype and function of CD8+ T lym-
phocytes and the in vitro response to IFN-a in relation to the
DNA damage response were investigated in patients with chronic
HCV infection.
Methods: CD8+ T lymphocytes with DSB were identiﬁed by
expression of c-H2AX (Ser-139) in 134 HCV-exposed subjects
and 27 controls. Telomere length was determined by ﬂow-FISH;
cytokine expression by intracellular cytokine staining; in vitro
responses to IFN-a, IL-2 or IL-6 by phospho-STAT1 (Y701) or
phospho-STAT5 (Y694) expression.
Results: The proportion of circulating CD8 + c-H2AX+ T lympho-
cytes rose with increasing ﬁbrosis stage (p = 0.0023). CD8 +
c-H2AX+ T lymphocytes were enriched in liver compared to
blood (p = 0.03). CD8 + c-H2AX+ T lymphocytes demonstrated
increased IFN-c (p = 0.02) and reduced IL-2 expression
(p = 0.02). CD8 + c-H2AX+ T lymphocytes failed to phosphorylate
STAT1 in response to IFN-a compared to unfractionated CD8+ T
lymphocytes (p <0.0001). More widespread failure of Jak/Stat sig-
nalling in CD8 + c-H2AX+ T lymphocytes was suggested by
impaired phosphorylation of STAT1 with IL-6 (p = 0.002) and
STAT5 with IL-2 (p = 0.0039) compared to unfractionated CD8+
T-lymphocytes.
Conclusions: In chronic HCV infection, CD8 + c-H2AX+ T lym-
phocytes are highly differentiated with shortened telomeres,
are more frequent within the liver, are associated with severeJournal of Hepatology 20
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Several factors inﬂuence the risk of progressive liver injury in
chronic hepatitis C virus (HCV) infection, including male sex
and alcohol misuse [1], but increasing age has perhaps the stron-
gest association with progressive ﬁbrosis and treatment failure
[2–4].
Healthy aging is associated with shortened telomeres in lym-
phoid and non-lymphoid cells [5,6]. Short telomeres are detected
by the MRN protein complex including MRE11, NBS1 and RAD50
[7,8], leading to recruitment of ataxia telangiectasia-mutated
(ATM) and ataxia telangiectasia and Rad3 related (ATR) serine/
threonine kinases [8,9]. A number of nuclear targets are phos-
phorylated subsequently, including Histone 2 at serine 139 to
form c-H2AX [10,11]. c-H2AX recruits further ATM complexes
to the site of its formation in a positive feedback loop and also
initiates stabilisation of p53 and its downstream target p21, lead-
ing ultimately to cell-cycle arrest [10,12].
Cellular responses to interferon-a (IFN-a) are important fol-
lowing exposure to HCV and during anti-viral therapy. IFN-a
binds to IFN-AR2, which forms a heterodimer with IFN-AR1, trig-
gering an intracellular signalling cascade through the Jak/Stat
pathway [13]. Phosphorylation of Jak1 and Tyk2 associated with
the intracellular tail of IFN-AR1 leads to phosphorylation of
STAT1 at tyrosine 701. Treatment outcome in HCV infected
patients is related closely to the transcriptome generated in
response to IFN-a [14–16].
HCV modulates cellular responses to endogenous IFN-a sig-
nalling through pSTAT1. HCV core prevents phosphorylation of
STAT1 in response to IFN-a [17] and NS5A prevents translocation
of pSTAT1 to the nucleus [18]. Shorter telomeres are associated
with defective activation of STAT5 in mouse macrophages [19].
In a previous study in chronic HCV infection progressive ﬁbro-
sis, an adverse clinical outcome and impaired treatment
responses were each associated with shortened CD8+ and CD4+13 vol. 58 j 868–874
Table 1. Demographic data of subjects in the four study groups.
Healthy controls HCV-RNA- HCV-RNA+ mild HCV-RNA+ severe p value†
N 27 27 59 48
Age (yr, mean ± SD) 42.0 ± 12.0 49.4 ± 7.5 48.8 ± 10.0 54.2 ± 6.2 0.0006
Sex (male, %) 48.1 66.6 71.2 79.2 0.04611
BMI (mean ± SD) 27.6 ± 4.2 24.6 ± 3.7 25.6 ± 4.6 26.7 ± 5.5 0.102
IgG anti-HBc+, % 13.6 52.0 25.0 38.3 0.01711
CMV Ab+, % 33.3 59.3 50.8 58.3 0.1611
Biochemical indices
Bilirubin (µmol/L, mean ± SD) - 7.4 ± 2.9 10.1 ± 5.3 13.3 ± 7.4 0.0001
ALT (IU/L, mean ± SD) - 27.6 ± 13.0 99.6 ± 79.4 110.3 ± 66.4 <0.0001
PT (sec, mean ± SD) - 12.6 ± 1.2 12.5 ± 0.7 13.7 ± 1.7 <0.0001
Signiﬁcant values are showed in bold.
Kruskal Wallis unless otherwise stated.
1Chi-squared.
JOURNAL OF HEPATOLOGYT-lymphocyte telomeres [20]. We therefore investigated the
in vitro response to IFN-a in CD8+ T cells in relation to shortened
telomeres and c-H2AX expression as a measure of double strand
DNA break signalling.Materials and methods
Subjects (Table 1)
Patients recruited at Addenbrooke’s Hospital, Cambridge gave written informed
consent with approval of the Local Research Ethics Committee. Patients co-
infected with HIV, HBV or with other chronic liver diseases, identiﬁed by history,
blood tests or liver biopsy, were excluded. Lymphocytes from healthy controls
were obtained from local volunteers; none gave a history of chronic illness or
intravenous drug usage. Liver biopsies were scored according to Ishak criteria
by a specialist liver histopathologist (SED). Fibrosis was staged 0 (absent)–6 (cir-
rhosis); mild liver disease was deﬁned as a ﬁbrosis score of 0–3 and severe 4–6.
Viral serology and PCR
Routine serology and PCR were performed in the Department of Virology, Adden-
brooke’s Hospital, Cambridge as described previously [20].
Lymphocyte preparation, culture and T-cell receptor directed stimulation
Peripheral blood mononuclear cells (PBMCs) were obtained by centrifugation of
citrated blood over Lymphoprep (Nycomed). Cells were cultured in RPMI-1640
medium supplemented with 2 mM L-glutamine, 10% foetal calf serum (Biosera),
100 IU/ml penicillin and 0.1 mg/ml streptomycin (Sigma–Aldrich).
Cells were cultured with or without variable concentrations of interferon-a2b
(PBL biomedical laboratories), IL-2 or IL-6 (Roche Applied Sciences).
Control (unstimulated) PBMC or PBMC stimulated with 1 lg/ml plate-bound
anti-CD3 and 4 lg/ml soluble anti-CD28 (BD) were incubated in a humidiﬁed 5%
CO2 atmosphere for 15 h. After 2 h, Brefeldin A (BD) was added according to the
manufacturer’s instructions.
Liver biopsy
See Supplementary Materials and methods.
Flow cytometry
All cytometry was performed on a FACSCanto II analyser (BD); data were ana-
lysed with FACSDiva software (BD).
PBMCs were stained for cell surface markers before ﬁxation in CALTAG med-
ium A. Cells were permeabilised in ice-cold 90% methanol (VWR) and then
stained with combinations of Alexa Fluor (AF) 488 or AF647 conjugated anti-c-Journal of Hepatology 201H2AX (Ser-139) (Cell Signaling) or other intracellular antigens or appropriate iso-
type controls. For further details of antibodies see Supplementary Materials and
methods.
A positive control for c-H2AX (PBMCs irradiated with 50 Gy) was included in
every run. Streptavidin-Cy3 (Cedarlane Labs) was utilised with biotinylated pri-
mary antibodies. Class 1 pentamer analysis was performed in HLA-A2 positive
individuals utilising HCV NS3 (KLVALGINAV) or CMV pp65 (NLVPMVATV) accord-
ing to the manufacturer’s instructions (Proimmune).
Telomere length by ﬂow cytometry
Telomere length of CD8+ T cells was measured using ﬂow-FISH assay [20]. CD4+
PBMCs from one healthy individual were analysed in every experiment as an
internal control. Lymphocyte telomere length within an individual was expressed
as mean ﬂuorescence intensity (MFI). CD8+ lymphocytes were negatively selected
using the CD8+ isolation kit II (Miltenyi Biotec) prior to staining and in situ
hybridisation. CD8+ purity always exceeded 90%.
Immunoblotting
See Supplementary Materials and methods.
Statistics
Data are the median (interquartile range), unless stated otherwise. c-H2AX
expression in different patient groups and cell surface phenotype of c-H2AX+
cells were analysed by Kruskal–Wallis test. Paired data from unfractionated
CD8+ and c-H2AX + CD8+ T cells were analysed by Wilcoxon signed rank test.
Absolute pSTAT1 responses and p53 expression were analysed by 2-way ANOVA.
Dose–response curves and EC50 were calculated by Prism 5.0 (Graphpad Soft-
ware). The correlation between c-H2AX expression and telomere length, age or
BMI was analysed by Spearman’s rank correlation.
Multiple linear regression analysis was performed to identify predictors of
c-H2AX expression using SPSS 15.0. Only variables with a p value of <0.10 on
univariate analysis were subjected to multivariate analysis. p values of <0.05 were
considered signiﬁcant.Results
Flow-cytometry was used to detect c-H2AX, a marker of DNA
double-strand breaks, to investigate the relation between periph-
eral CD8+ T-lymphocyte telomere length and downstream signal-
ling (Fig. 1A). Subjects with CD8 + CD45RO+ T lymphocytes with
shortened telomeres had an increased proportion of circulating
c-H2AX + CD8+ T lymphocytes (p = 0.006, Rs = 0.23, Fig. 1B).
The proportion of circulating c-H2AX + CD8+ T lymphocytes in
HCV-RNA+ patients with severe ﬁbrosis (median 2.8% (1.5–4.6))3 vol. 58 j 868–874 869
Fig. 1. c-H2AX (Ser-139) expression on circulating CD8+ T lymphocytes in
healthy controls and HCV-infected subjects. (A) Gating strategy for c-H2AX;
cells within the live lymphocyte gate by scatter characteristics (left panel) and
positive staining for CD8 (centre panel) were studied. Isotype control staining
pattern in ﬁlled histogram; positive control staining pattern from irradiated cells in
dashed histogram, and experimental sample in bold histogram (right panel). (B)
Association between telomere length in CD8 + CD45RO+ subsets and c-H2AX
expression. Correlation by Spearman’s rank. (C) c-H2AX levels in CD8+ T
lymphocytes (27 controls, 27 HCV-RNA- HCV-exposed cases, 59 HCV-RNA+
patients with mild ﬁbrosis and 48 HCV-RNA+ patients with severe ﬁbrosis) by
study group allocation. (D) Co-expression of c-H2AX and phospho-p53 (Ser 15) in
CD8+ T lymphocytes from subjects with viraemic HCV infection. (E and F) Co-
expression of c-H2AX and Ki67 in CD8+ T lymphocytes from 10 HCV-RNA+
subjects. Analysis by Wilcoxon signed rank test. (G) Cell-surface phenotype of
circulating c-H2AX + CD8+ T lymphocytes from subjects (n = 60) with HCV
infection. CD8+ lymphocytes were divided based on the expression of the surface
markers CD27 and CD57. Statistical analysis by Friedman testwith Dunn’smultiple
comparison test. (H) CD8+ T lymphocyte telomere length from CD8+ subsets based
on CD27 expression from10HCV-RNA+ subjects. (I) Immunoblot ofmagnetic-bead
separated CD8 + CD27+ and CD27- cells for c-H2AX and b-actin. Irradiated whole
CD8+ lymphocytes were a positive control for c-H2AX expression.
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Research Articlewas higher than in healthy controls (1.8% (0.98–2.4)), HCV-RNA-
negative HCV-exposed subjects (2.0% (1.1–3.5)) and HCV-RNA-
positive patients with mild ﬁbrosis (1.4% (0.8–2.4), Kruskal Wallis
p = 0.0023, Fig. 1C).
To study the independent association between clinical and
demographic factors with CD8+ T-lymphocyte c-H2AX expres-
sion in HCV-RNA+ subjects (n = 109), a multiple linear regression
model was constructed (Supplementary Fig. 1 and Table 2). By
univariate analysis, increased ﬁbrosis stage (p <0.001) and a
low ALT (p = 0.059) were associated with increased c-H2AX
expression. On multivariate analysis, increased ﬁbrosis stage870 Journal of Hepatology 201(p <0.001) and low ALT (p = 0.025) were independently associated
with increased c-H2AX expression (Table 2).
There was increased c-H2AX expression on CD8+ T lympho-
cytes in subjects with past exposure to CMV (Supplementary
Fig. 1G–I), which is probably explained by a higher proportion
of CD8+ T lymphocytes with an advanced cell surface phenotype,
deﬁned by CD27 and CD57 expression and described previously
in CMV [21] (Supplementary Fig. 1H). There was no increase in
c-H2AX expression when the analysis was restricted to the
CD27- subset, controlling for this increase in highly differentiated
cells (Supplementary Fig. 1I).
c-H2AX expression was associated with evidence of down-
stream DNA damage response (DDR) signalling, as c-H2AX +
CD8+ T lymphocytes had increased phosphorylation of p53 at
serine 15 (Fig. 1D). There was no difference in Ki67 expression
between unfractionated CD8+ T lymphocytes (0.7%; 0.57–1.15)
and c-H2AX + CD8+ T lymphocytes (1.3%; 0.45–1.75, p = 0.24,
Fig. 1E and F), indicating c-H2AX expression was unrelated to
DNA replication.
c-H2AX was present in a higher proportion of CD8+ T lympho-
cytes expressing the mature phenotypes CD27-CD57- (3.1% (1.4–
5.6)) or CD27-CD57+ (3.2% (1.7–6.2)) than the less mature
CD27 + CD57- subset (0.8% (0.4–1.6), p <0.0001, Fig. 1G). Consis-
tent with this observation, CD8 + CD27- T lymphocytes had
shorter telomeres (117 (111 – 134)) than CD8 + CD27+ T lympho-
cytes (146 (139–161), p = 0.0003, Fig. 1H). Immunoblotting
revealed increased c-H2AX expression in CD8 + CD27- T lympho-
cytes compared to CD8+ CD27+ T lymphocytes (Fig. 1I).
Without stimulation, a higher proportion of c-H2AX + CD8+ T
lymphocytes expressed IFN-c (3.9% (2.48–13.5)) compared with
unfractionated CD8+ T lymphocytes (0.4% (0.08–1.2), p = 0.002,
Fig. 2A). Following overnight stimulation (with anti-CD3 and
anti-CD28), a higher proportion of c-H2AX + CD8+ T lymphocytes
expressed IFN-c (20.0% (7.8–26.9) comparedwith 9.6% (4.9–18.1),
p = 0.02) than unfractionated CD8+ T lymphocytes (Fig. 2C). How-
ever, the proportion of unstimulated c-H2AX + CD8+ T cells
expressing IL-2 was lower than unfractionated CD8+ T lympho-
cytes (1.8% (0–3.1) compared with 3.1% (2–5.3), p = 0.03, Fig. 2D).
We studied co-expression of c-H2AX and markers of activa-
tion and known inhibitory receptors. c-H2AX + CD8+ T cells were3 vol. 58 j 868–874
Table 2. Clinical and demographic factors associated with c-H2AX expression on CD8+ T lymphocytes from HCV-RNA+ subjects (n = 109) by multiple linear
regression.
Univariate analysis Multiple linear regression
Standardised
Beta
t p value Standardised
Beta
t p value
(Constant) 0.285 0.777
Sex 0.014 0.131 0.896
Age 0.103 1.000 0.320
Fibrosis stage 0.414 3.611 0.000 0.405 4.378 0.000
ALT -0.192 -1.909 0.059 -0.209 -2.276 0.025
Bilirubin -0.014 -0.146 0.884
PT -0.046 -0.401 0.689
BMI -0.017 -0.164 0.870
Past CMV 0.014 0.138 0.891
Past HBV 0.181 1.757 0.082 0.155 1.693 0.093
Signiﬁcant values are showed in bold.
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Journal of Hepatology 201CD38 positive, but CD69 negative (Supplementary Fig. 2). Further,
these cells did not express the inhibitory receptors PD-1 or Tim3
(Supplementary Fig. 2). c-H2AX + CD8+ T cells were negative for
CD161 [22] in 15 further patients with viraemic HCV infection
(data not shown). To study potential antigen-speciﬁcity, circulat-
ing c-H2AX + CD8+ T lymphocytes derived from three HLA-2
positive patients with positive CMV serology and current HCV
infection (HCV-RNA+ in serum) showed no speciﬁcity for either
HCV-NS3 or CMV-pp65, although unfractionated CD8+ T lympho-
cytes responded to both pentamers (Supplementary Fig. 3).
Induction of pSTAT1 expression was used as a measure of the
response to in vitro IFN-a (Fig. 3A and B). CD8+ T lymphocytes
from healthy controls responded with an EC50 of 99 IU/ml.
Unfractionated CD8+ T lymphocytes from HCV-infected subjects
had an increased EC50 when compared to healthy controls
(308 IU/ml), which was still higher in c-H2AX + CD8+ T lympho-
cytes (781 IU/ml) (Fig. 3A–C). The maximal response of unfrac-
tionated CD8+ T lymphocytes from HCV infected patients was
similar to that in healthy controls (p = 0.29, Fig. 3D) but the
response of c-H2AX+ T lymphocytes was impaired by compari-
son (p <0.0001). These defects could not be explained by total
STAT1 content (Supplementary Fig. 4A and B), surface expression
of IFN-AR components (Fig. 3E-G), failure to phosphorylate Tyk2
or Jak1 (Supplementary Fig. 4C and D) or IFN-a induced downreg-
ulation of IFN-AR from the cell surface of c-H2AX + CD8+ T lym-
phocytes (Fig. 3H).
A higher proportion of intrahepatic CD8+ T lymphocytes
expressed c-H2AX (2.15%, (1.28–3.65)) compared to circulatingFig. 2. Cytokine expression pattern of peripheral CD8+ T lymphocytes from 10
subjects with chronic HCV infection. Unfractionated CD8+ lymphocytes or
c-H2AX + CD8+ subsets were analysed for expression of (A and C) IFN-c, and
(B and D) IL-2. Cells were either (A and B) unstimulated or (C and D) stimulated
with anti-CD3/anti-CD28 overnight. Analysis by Wilcoxon signed rank test.
Failure of several Jak/Stat signalling pathways in c-H2AX + CD8+ T lymphocytes
from HCV-RNA+ subjects (n = 10). Circulating T lymphocytes were incubated
with IL-2 or IL-6 before staining for CD8, c-H2AX and pSTAT1 (Tyr 701) or pSTAT5
(Tyr 694). Example dot-plots of CD8+ gated T lymphocytes incubated with (E) 0.1
or 10 IU/ml IL-2 or (F) 3 or 300 IU/ml IL-6. Panels G and H demonstrate
the proportion of whole CD8+ and c-H2AX + CD8+ T lymphocytes expressing
(G) IL-6-induced phospho-STAT1 and (H) IL-2 induced phospho-STAT5. Analysis
by Wilcoxon signed rank test.
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lymphocyte subsets deﬁned by c-H2AX. Analysis by 2-way ANOVA. Failure of CD8 + c-H2AX + cells to phosphorylate STAT1 does not relate to STAT1 expression or IFN-a
receptor components. (E and F) Expression of IFN-AR2 on whole CD8+ and c-H2AX + CD8+ lymphocytes from HCV-RNA+ subjects (n = 18); (E) example cytometric data of
IFN-AR2 and c-H2AX co-expression; (F) IFN-AR2 expression in whole and c-H2AX + CD8+ lymphocytes. (G and H). Expression and downregulation of IFN-AR1 on whole
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AR1 expression in c-H2AX + CD8+ lymphocytes from HCV-RNA+ subjects (n = 6) cultured in medium alone or with 300 IU/ml IFN-a2b for 24 h. Analysis by 2-way ANOVA.
Research ArticleCD8+ T lymphocytes simultaneously isolated (0.25% (0.1–1.43),
p = 0.03, Fig. 4A and B). Intrahepatic c-H2AX + CD8+ T lympho-
cytes had a similar phenotype to circulating T lymphocytes with
low expression of CD27 (Fig. 4C). Intrahepatic c-H2AX + CD8+ T
lymphocytes also failed to phosphorylate STAT1 in response to
IFN-a2b (Fig. 4D).
To investigate whether the defect in Jak/Stat signalling was
conﬁned to the IFN-a pathway, the response of c-H2AX + CD8+
T lymphocytes to IL-6 was investigated, as this also signals
through STAT1. The proportion of unfractionated CD8+ T lympho-
cytes that expressed pSTAT1 after exposure to 300 IU/ml IL-6 was
higher than in c-H2AX + CD8+ T lymphocytes (16.4% (12.3–28.4
and 3.9% (1.9–5.6), p = 0.002, Fig. 2E and G) suggesting that defec-
tive STAT1 phosphorylation was not conﬁned to IFN-a signalling.
IL-2-induced STAT5 phosphorylation was investigated to
determine if there was an overall failure of Stat activation in
c-H2AX + CD8+ T-lymphocytes. After exposure to 10 IU/ml IL-2
the proportion of unfractionated CD8+ T lymphocytes that
expressed pSTAT5 was higher than in c-H2AX + CD8+ T lympho-
cytes (36.2% (23.6–39.5) and 2.7% (1.8–6.8), p = 0.0039, Fig. 2F
and H) suggesting a more widespread failure of Jak/Stat signalling
in c-H2AX + CD8+ T-lymphocytes.Discussion
c-H2AX expression in circulating lymphocytes, induced by DSBs
and indicative of DDR activation, correlated with reduced telo-
mere length in CD8+ T cells and ﬁbrosis stage. The correlation
between ﬁbrosis stage and the small proportion of circulating872 Journal of Hepatology 201c-H2AX-positive lymphocytes was perhaps surprising and may
reﬂect accelerated ageing in many tissues including the liver, or
a more direct, potent effect mediated through the secretory phe-
notype of senescent cells. c-H2AX expression was conﬁned to T
cells with an advanced cell-surface phenotype and associated
with a skewed cytokine expression proﬁle (increased IFN-c with
reduced IL-2) consistent with previous data in CD4+ T lympho-
cytes in HCV infection [23]. c-H2AX + CD8+ T lymphocytes had
impaired phosphorylation of STAT1 in response to exogenous
IFN-a, which was not explained by altered expression of
IFN-AR2 or IFN-AR1, or there was evidence that the failure to
phosphorylate Jak1 and Tyk2 was associated with the intra-
cellular apparatus of the IFN-a receptor. c-H2AX + CD8+ T lym-
phocytes are more abundant within HCV-infected liver and had
similar surface phenotype and functional deﬁcits to circulating
c-H2AX + CD8+ T-lymphocytes.
There was an unexplained mechanistic association between
telomere shortening, downstream signalling and the failure of
c-H2AX positive cells to respond to IFN-a by phosphorylation
of STAT1. Possible explanations include a lesion of either Jak1
or Tyk2 [24], expression of the truncated isoform of IFN-AR2
[25] or suppression of signalling through the suppressor of cyto-
kine signalling (SOCS) family of proteins [26].
Pre-translational processing involving mRNA splicing can
result in expression of a truncated isoform of IFN-AR2, which
suppresses signalling through the IFN-AR complex to intracellu-
lar second messengers [25]. Murine cell lines, infected with
VZV, failed to suppress viral replication when signalling through
the isoform with a truncated cytoplasmic tail, in contrast to full
length IFN-AR2. Human cells normally express the truncated3 vol. 58 j 868–874
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Fig. 4. CD8+ c-H2AX+ T lymphocytes are more frequent within the liver of
HCV-infected subjects. (A) Example plots of CD8 and c-H2AX expression on
peripheral (left panel) and intrahepatic (right panel) lymphocytes from an HCV-
RNA+ subject. (B) Expression of c-H2AX on circulating and intrahepatic CD8+ T
lymphocytes from 6 HCV infected subjects. Analysis byWilcoxon signed rank test.
(C) Co-expression of CD27 and c-H2AX on intrahepatic CD8+ T lymphocytes. (D)
Response of hepatic CD8+ T lymphocytes to in vitro IFN-a through STAT1
phosphorylation. Example dot-plots of hepatic CD8+ T lymphocytes incubated
with 10 IU/ml (left panel) or 1000 IU/ml IFN-a2b (right panel).
JOURNAL OF HEPATOLOGYisoform at low levels compared to the full length biologically
active form [27]. However, studies have demonstrated that other
chronic viral infections modulate the frequency of IFN-AR splice
isoforms [27,28].
Hepatitis D virus suppresses IFN-a signalling through inhibi-
tion of Tyk2 phosphorylation, preventing STAT1 phosphorylation
and activation [24]. Our data precluded a similar mechanism, but
there may be a failure of kinase function of the activated intracel-
lular tail of the IFN-a receptor.
c-H2AX expression often reﬂects the cellular response to
shortened telomeres, but is also generated at the site of any break
in double-stranded DNA. c-H2AX expression is related to critical
telomere shortening, but that is not the only explanation
[10,11,29]. In cells exposed to increased DNA damage, through
oncogene or oxidative stress, the direct correlation between
c-H2AX expression and telomere length can be lost. Senescence,
however induced, leads to increased ROS production, leading to
increased DSB foci within the cell [30]. Viruses, including EBV,
induce c-H2AX in infected cells [31]. Herpes virus c-HV68 infec-
tion in a murine model led to c-H2AX induction, which in turn
increased viral replication [31]. Viruses induce cell-cycle arrest
in order to generate a more favourable environment for replica-
tion. A direct effect of HCV on c-H2AX expression in T cells is fea-
sible, but was not investigated.
Chronic exposure of cells to IFN-b, but not IFN-a, led to irre-
versible p53-dependent cell-cycle arrest [32], whereby ﬁbro-
blasts exposed to IFN-b for 6 days developed c-H2AX
expression, accumulation of mitochondrial-derived ROS and fail-
ure of proliferation. Perhaps the failure to demonstrate a strongerJournal of Hepatology 201correlation between c-H2AX and telomere length in patients
with chronic HCV infection relates to chronic exposure of lym-
phocytes to IFN-a and subsequent expression of c-H2AX. How-
ever, c-H2AX + cells have increased expression of IFN-AR1,
normally negatively regulated by IFN-a, which would suggest
that these cells have not been stimulated through this pathway
in vivo.
In a previous study, the degree of DNA damage in circulating
lymphocytes in HCV-related, HBV-related and alcohol-related cir-
rhosis [33] correlated with the Child-Pugh score. Why circulating
lymphocytes demonstrate DNA damage in patients with cirrhosis
is unclear. Although we have excluded the possibility that
c-H2AX positive cells do not react to a single HLA-A2 restricted
HCV epitope, it is possible that they might react to other epitopes
in a non-HLA-A2 restricted fashion. However, we believe this
unlikely given that the cells also do not react with the typically
immunodominant A2-restricted pp65 epitope for CMV. Several
previous studies have postulated the role of a bystander effect
induced by chronic cytokine secretion in response to chronic viral
infection leading to telomerase inhibition in the general, rather
than antigen-speciﬁc, T-lymphocyte population [34]. It is plausi-
ble that c-H2AX positive cells represent a multi-speciﬁc memory
cell population that has re-circulated through the chronically
inﬂamed liver in the context of HCV infection. Higher proportions
of c-H2AX positive cells in the liver would support this possibil-
ity. However, other groups have demonstrated that HCV infection
is associated with a failure of maturation of non-HCV speciﬁc
cells. Lucas et al. demonstrated that CMV-speciﬁc CD8+ T lym-
phocytes in HCV had fewer surface markers of an advanced dif-
ferentiation state compared to non-HCV infected subjects [35].
Chronic HCV infection modulates the response to IFN-a
through pSTAT1. HCV-NS5A prevents phosphorylation and
nuclear translocation of pSTAT1 [18]. HCV-transfection of HuH7
cells leads to enhanced pSTAT1 degradation [36]. The N-terminal
portion of HCV-core binds to the C-terminal portion of STAT1,
blocking both homo- and hetero-dimerisation, preventing its
intracellular actions [17]. HCV core protein reduced pSTAT1 in
circulating T lymphocytes but increased pSTAT1 in B-lympho-
cytes HCV [37]. These ﬁndings may explain in part the increased
EC50 for IFN-a in HCV infection, but not the very signiﬁcant path-
way defects seen in c-H2AX + CD8+ T cells.
The failure to respond to IL-6 and IL-2 by phosphorylation of
STAT1 and STAT5 respectively suggests a broader defect in senes-
cent T lymphocytes in response to exogenous cytokine signals.
CD8+ c-H2AX+ T lymphocytes have shortened telomeres, are
highly differentiated, associated with severe ﬁbrosis, are more
frequent within the liver and although they have evidence of
effector function (IFN-c expression), do not activate Jak/Stat
pathways in response to IFN-a, IL-2 or IL-6, perhaps explaining
the failure of older patients and those with severe ﬁbrosis to
respond to treatment. Deﬁning the cellular pathway linking
advanced ﬁbrosis, telomere shortening and failure to respond to
IFN-a therapy could be important.Financial support
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